In the United States, the FDA has approved daraxonrasib, a new targeted oral treatment for previously treated metastatic pancreatic adenocarcinoma, which has been shown to double the median survival of patients to 13.2 months compared to the 6.7 months provided by standard chemotherapy. (translated)
Una terapia a base di cellule staminali ha portato a una remissione di 15 anni in pazienti affetti da neuromielite ottica, mostrando miglioramenti significativi nelle funzioni neurologiche, ma anche alcuni effetti collaterali come linfonodi ingrossati e un tumore alla vescica, suggerendo la necessità di ulteriori studi clinici. #NeuromieliteOttica #CelluleStaminali #TerapiaInnovativa
### EXTRAORDINARY EDITION ### A NEW REVOLUTIONARY THERAPY FOR METASTATIC PANCREATIC CANCER Just released a few hours ago a work with exceptional results never seen before. Finally an extraordinary edition for good news and not for a new danger. Link in bio https://t.co/ZQhBFZq0Kj (translated)
